Andrew Kraft, MD

Andrew Kraft, MD

Hematology Charleston, SC

Professor of Medicine, Med University SC


Office Address

  • 171 Ashley Ave
    Charleston, SC 29425
    Phone: (843) 792-1414

Are you Dr. Kraft?

Claim your profile and join over 50% of U.S. physicians already on Doximity.

Claim this pageNo, this isn't me

Andrew Kraft, MD

Hematology Charleston, SC

Professor of Medicine, Med University SC

50 Colleague InvitesIs this you? Register Now to see 50 messages.

Summary

  • Dr. Andrew Kraft, MD is a board certified hematologist in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina. He is affiliated with Medical University of South Carolina and Ralph H. Johnson VA Medical Center.

Clinical Specialties & Interests

  • Hematology: General Hematology

Education & Medical Training

  • Mount Sinai School of MedicineMount Sinai School of Medicine
  • National Institutes of Health Clinical CenterNational Institutes of Health Clinical Center
  • Perelman School of Medicine at the University of PennsylvaniaPerelman School of Medicine at the University of Pennsylvania

Certifications & Licensure

  • AZ State Medical LicenseAZ State Medical License2014 - 2016
  • SC State Medical LicenseSC State Medical LicenseActive through 2013
  • American Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineMedical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 CertificationEpicCare Ambulatory EMR, Epic Systems Corporation, 2012, 2013
  • Elected MemberThe American Society for Clinical Investigation, 1993

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Senior LeadershipNational Cancer Institute
    2009 - 2012
  • Program Planning And EvaluationNational Cancer Institute
    2009 - 2012
  • Medical University Of South Carolina - Cancer Center Support GrantNational Cancer Institute
    2009 - 2012
  • Novel Inhibitors Of PIM Protein KinasesNational Cancer Institute
    2009 - 2009
  • Developmental FundsNational Cancer Institute
    2009 - 2012
  • Mechanisms By Which Proteasome Enhance ApoptosisNational Cancer Institute
    2004 - 2007
  • Mechanisms By Which Proteasome Enhance ApoptosisNational Cancer Institute
    2004 - 2004
  • Hollings Cancer Center Planning GrantNational Cancer Institute
    2003 - 2005
  • PIM 1 Protein Kinase As A Target For Drug DiscoveryNational Cancer Institute
    2003 - 2003
  • PIM 1 Protein Kinase As A Target For Drug DiscoveryNational Cancer Institute
    2002 - 2003
  • Developmental Therapeutics ProgramsNational Cancer Institute
    2001 - 2002
  • Control Of Differentiation Of Human PromyelocytesNational Cancer Institute
    1999 - 2003
  • Phase II Trial Of Bryostatin 1 For Treatment Of Stage IV Breast CancerNational Center For Research Resources
    1999 - 2002
  • Training In Pharmacology Of Antineoplastic AgentsNational Cancer Institute
    1999 - 2003
  • Regulation Of Prostate Cancer Programmed Cell DeathNational Cancer Institute
    1998 - 2001
  • Phase I/II RX Of Chronic Myelogenous Leukemia With Bryostatin 1National Center For Research Resources
    1998 - 2000
  • Bryostatin 1 Treatment For Patients With Metastatic Malignant MelanomaNational Center For Research Resources
    1998 - 2000
  • Mechanism Of Action Of GM-CSFNational Institute Of Diabetes And Digestive And Kidney Diseases
    1997 - 2000
  • Bryostatin1 In Chronic Myelogenous LeukemiaNational Center For Research Resources
    1997 - 1997
  • Differentiation Therapy Of Chronic Myelogenous LeukemiaNational Cancer Institute
    1996 - 1996
  • Bryostatin 1 In Metastatic Malignant MelanomaNational Center For Research Resources
    1996 - 1997
  • Control Of Differentiation Of PromyelocytesNational Cancer Institute
    1996 - 1998
  • Bryostatin 1 Therapy Of Metastatic MelanomaNational Cancer Institute
    1996 - 1996
  • Bryostatin 1 Therapy Of Metastatic MelanomaNational Cancer Institute
    1995 - 1995
  • Differentiation Therapy Of Chronic Myelogenous LeukemiaNational Cancer Institute
    1995 - 1996
  • Control Of Differentiation Of PromyelocytesNational Cancer Institute
    1994 - 1996
  • Mechanism Of Action Of GM-CSFNational Institute Of Diabetes And Digestive And Kidney Diseases
    1992 - 1995
  • The Role Of Protein Kinase C In Mediating N-RAS ProteinFogarty International Center
    1989 - 1989
  • Control Of Differentiation Of Human PromyelocytesNational Cancer Institute
    1986 - 1993

Insurance Accepted

  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Andrew Kraft, Dr. Andrew Kraft, MD, Dr. A Kraft, Dr. Andrew S Kraft

Physicians, view Dr. Kraft's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV

© 2015 Doximity, Inc.GroupsHelpBlogCompanyContactPrivacyDirectory